MAP2K1 and neoplasm: The MEK1/2 inhibitor alone directly induced tumor cell death, decreased the frequency of intratumoral Tregs and TAMs, yet selectively targeted immunosuppressive TAMs and MDSCs while sparing inflammatory TAMs (146).